Articles
Malania L, Wagenaar I, Karatuna O, Tambic Andraesevic A, Tsereteli D, Baidauri M, Imnadze P, Nahrgang S, Ruesen C. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia. ScienceDirect 2021; 27(10):1409-1413.
Van Prehn J, van Triest MI, Altorf-van der Kuil W, van Dijk K; Dutch National AMR Surveillance Study Group. Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands. Clin Microbiol Infect 2019; 25(4):518-520
Woudt SHS, de Greeff S1, Schoffelen A1, Vlek ALM, Bonten MJM; Infectious Diseases Surveillance Information System–Antimicrobial Resistance (ISIS-AR) Study Group
Antibiotic resistance and the risk of recurrent bacteremia
Clin Infect Dis 2018; 66(11):1651-7
Altorf-van der Kuil W, Schoffelen AF, de Greeff SC, Thijsen SF, Alblas HJ, Notermans DW, Vlek AL, van der Sande MA, Leenstra T; The National Amr Surveillance Study Group.
National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands.
Euro Surveill 2017; 22(46):pii.17-00062
Vlek AL, Frentz D, Haenen A, Bootsma HJ, Notermans DW, Frakking FN, de Greeff SC, Leenstra T; ISIS-AR study group.
Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014
Eur J Clin Microbiol Infect Dis 2016; 35(7):1089-96
Koningstein M, van der Bij AK, de Kraker ME, Monen JC, Muilwijk J, de Greeff SC, Geerlings SE, van Hall MA; ISIS-AR Study Group
Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands
PLoS One. 2014 Jan 28;9(1):e86634. doi: 10.1371/journal.pone.0086634. PubMed PMID: 24489755; PubMed Central PMCID: PMC3904917
Houben AJ, Oostdijk EA, van der Voort PH, Monen JC, Bonten MJ, van der Bij AK; ISIS-AR Study Group
Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands
J Antimicrob Chemother. 2014 Mar;69(3):797-804. doi: 10.1093/jac/dkt416. PubMed PMID: 24144922
Leverstein-van Hall MA, Waar K, Muilwijk J, Cohen Stuart J; ISIS-AR Study Group
Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli.
J Antimicrob Chemother. 2013 Nov;68(11):2636-40. doi: 10.1093/jac/dkt218. PubMed PMID: 23766488
van der Bij AK, van Dijk K, Muilwijk J, Thijsen SF, Notermans DW, de Greeff S, van de Sande-Bruinsma N; ISIS-AR study group
Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia
Clin Microbiol Infect. 2012 Nov;18(11):E466-72. doi: 10.1111/j.1469-0691.2012.03996.x. PubMed PMID: 22925456
Reports
CAESAR Annual report 2020
CAESAR Annual report 2019